Clinical Trial Update: Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Beta Alethine for Waldenström's macroglobulinemia is reported. Sponsor is LifeTime Pharmaceuticals and the trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Beta Alethine (beta alethine)

Snippet

Sponsor: LifeTime Pharmaceuticals | Conditions: Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN